166 related articles for article (PubMed ID: 6456228)
1. Vaginal isolates of Staphylococcus aureus associated with toxic shock syndrome.
Barbour AG
Infect Immun; 1981 Aug; 33(2):442-9. PubMed ID: 6456228
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the hemolytic activity of Staphylococcus aureus strains associated with toxic shock syndrome.
Chow AW; Gribble MJ; Bartlett KH
J Clin Microbiol; 1983 Mar; 17(3):524-8. PubMed ID: 6841587
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome.
Todd JK; Franco-Buff A; Lawellin DW; Vasil ML
Infect Immun; 1984 Aug; 45(2):339-44. PubMed ID: 6378794
[TBL] [Abstract][Full Text] [Related]
4. Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model.
Rasheed JK; Arko RJ; Feeley JC; Chandler FW; Thornsberry C; Gibson RJ; Cohen ML; Jeffries CD; Broome CV
Infect Immun; 1985 Mar; 47(3):598-604. PubMed ID: 3156093
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Staphylococcus aureus isolates from patients with toxic shock syndrome, using polyethylene infection chambers in rabbits.
Scott DF; Kling JM; Kirkland JJ; Best GK
Infect Immun; 1983 Jan; 39(1):383-7. PubMed ID: 6822419
[TBL] [Abstract][Full Text] [Related]
6. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
Bonventre PF; Weckbach L; Harth G; Haidaris C
Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
[TBL] [Abstract][Full Text] [Related]
7. Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus.
Lee JC; Liu MJ; Parsonnet J; Arbeit RD
J Clin Microbiol; 1990 Dec; 28(12):2612-5. PubMed ID: 2279990
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus in toxic shock syndrome and other surgical infections. Development of new bacteriophages.
Altemeier WA; Lewis SA; Bjornson HS; Staneck JL; Schlievert PM
Arch Surg; 1983 Mar; 118(3):281-4. PubMed ID: 6218795
[TBL] [Abstract][Full Text] [Related]
9. Toxic-shock syndrome: a commentary and review of the characteristics of Staphylococcus aureus strains.
Chesney PJ
Infection; 1983; 11(4):181-8. PubMed ID: 6352506
[TBL] [Abstract][Full Text] [Related]
10. Enterotoxin production by strains of Staphylococcus aureus isolated from clinical and non-clinical specimens with special reference to enterotoxin F and toxic shock syndrome.
de Nooij MP; van Leeuwen WJ; Notermans S
J Hyg (Lond); 1982 Dec; 89(3):499-505. PubMed ID: 6218196
[TBL] [Abstract][Full Text] [Related]
11. Staphylococci associated with toxic shock syndrome in the United Kingdom.
de Saxe MJ; Wieneke AA; de Azevedo J; Arbuthnott JP
Ann Intern Med; 1982 Jun; 96(6 Pt 2):991-6. PubMed ID: 6212009
[TBL] [Abstract][Full Text] [Related]
12. Toxic shock syndrome toxin-1 (TSST-1) production and phage susceptibility of Staphylococcus aureus strains from human vaginas and anterior nares in Trinidad.
Adesiyun AA; Singh D; Gunness RI
Zentralbl Bakteriol; 1994 Jan; 280(3):371-81. PubMed ID: 8167431
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.
Schlievert PM; Shands KN; Dan BB; Schmid GP; Nishimura RD
J Infect Dis; 1981 Apr; 143(4):509-16. PubMed ID: 6972418
[TBL] [Abstract][Full Text] [Related]
14. Induction of interleukin-1 by strains of Staphylococcus aureus from patients with nonmenstrual toxic shock syndrome.
Parsonnet J; Gillis ZA; Pier GB
J Infect Dis; 1986 Jul; 154(1):55-63. PubMed ID: 3486924
[TBL] [Abstract][Full Text] [Related]
15. Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay.
Rosten PM; Bartlett KH; Chow AW
J Clin Microbiol; 1987 Feb; 25(2):327-32. PubMed ID: 3818927
[TBL] [Abstract][Full Text] [Related]
16. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
[TBL] [Abstract][Full Text] [Related]
17. Production of toxic shock syndrome-like illness in rabbits by Staphylococcus aureus D4508: association with enterotoxin A.
McCollister BD; Kreiswirth BN; Novick RP; Schlievert PM
Infect Immun; 1990 Jul; 58(7):2067-70. PubMed ID: 2365451
[TBL] [Abstract][Full Text] [Related]
18. Crystal violet binding, cell surface properties and extracellular enzyme profiles of Staphylococcus aureus producing toxic shock syndrome toxin-1.
Naidu AS; Jimenez J; Rollof J; Aleljung P; Nilsson-Ehle P; Larsson L; Hedström SA
Zentralbl Bakteriol; 1989 May; 271(1):11-21. PubMed ID: 2669786
[TBL] [Abstract][Full Text] [Related]
19. Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources.
Bonventre PF; Weckbach L; Staneck J; Schlievert PM; Thompson M
Infect Immun; 1983 Jun; 40(3):1023-9. PubMed ID: 6189784
[TBL] [Abstract][Full Text] [Related]
20. Production of gamma-hemolysin and lack of production of alpha-hemolysin by Staphylococcus aureus strains associated with toxic shock syndrome.
Clyne M; De Azavedo J; Carlson E; Arbuthnott J
J Clin Microbiol; 1988 Mar; 26(3):535-9. PubMed ID: 3356791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
